| Bioactivity | KY-04045 is a PAK4 specific inhibitor (IC50=8.7 μM) that can be used for the development of anticancer drugs targeting PAK4[1]. |
| CAS | 1223284-75-0 |
| Formula | C13H14BrN5 |
| Molar Mass | 320.19 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Park, et al. "The discovery and the structural basis of an imidazo [4, 5-b] pyridine-based p21-activated kinase 4 inhibitor." Bioorganic & medicinal chemistry letters 26.11 (2016): 2580-2583. |